Thrombocytopenia, unspecified

D3_THROMBOCYTOPENIANAS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D69.6 Hospital discharge: ICD-9 — 2875 Hospital discharge: ICD-8 — 28719\|2872 Cause of death: ICD-10 — D69.6 Cause of death: ICD-9 — 2875 Cause of death: ICD-8 — 28719\|2872 2 out of 7 registries used, show all original rules.	2664
4. Check minimum number of events None	2664
5. Include endpoints None	2664
6. Filter based on genotype QC (FinnGen only)	2664

Control definitions (FinnGen only)

Control exclude: D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D69
Name in latin: Thrombocytopenia NAS

NAME	D3_THROMBOCYTOPENIANAS
CONTROL_EXCLUDE	D3_COAGDEF_PURPUR_HAEMORRHAGIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D696
HD_ICD_9	2875
HD_ICD_8	28719\|2872
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D696
COD_ICD_9	2875
COD_ICD_8	28719\|2872
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Thrombocytopenia, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20979	9790	11000
Only index persons	17647	8393	9254
Unadjusted period prevalence (%)
Whole population	0.29	0.28	0.31
Only index persons	0.33	0.31	0.35
Median age at first event (years)
Whole population	60.24	59.26	61.06
Only index persons	59.45	57.70	61.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2664	1256	1408
Unadjusted period prevalence (%)	0.53	0.43	0.62
Median age at first event (years)	60.84	55.70	65.43

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2400: Matched controls
23998

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

16384.0

323.0

2253

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

+∞

323.0

509

XW000

NOMESCO Finland

Bone marrow biopsy

28.5

323.0

743

372

WW500

NOMESCO Finland

Blood transfusion

17.0

301.0

501

367

D64.9

ICD-10 Finland

Anaemia, unspecified

6.5

219.0

651

1304

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

10.6

204.7

423

474

D70.82

ICD-10 Finland

Drug-induced neutropenia

19.8

152.0

235

131

D70.89

ICD-10 Finland

Neutropenic splenomegaly

27.2

141.8

198

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

8.6

130.1

300

393

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.0

126.4

588

1788

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

629.0

122.4

120

28719

ICD-8 Finland

Purpura and other haemorrhagic conditions, Thrombocytopenia NUD

+∞

121.9

116

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

13.6

119.7

214

171

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.2

115.3

508

1457

L03AA02

ATC

filgrastim; parenteral

10.3

104.3

214

226

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

103.5

1285

7441

R50.9

ICD-10 Finland

Fever, unspecified

3.4

94.8

541

1894

H02AB06

ATC

prednisolone; systemic

2.4

93.4

1309

7916

D69.5

ICD-10 Finland

Secondary thrombocytopenia

+∞

93.3

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.9

91.3

241

381

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

15.1

86.6

147

103

JN4BD

NOMESCO Finland

Extensive body CT

3.5

84.3

446

1459

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

101.4

80.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.9

78.7

362

1050

M04AA01

ATC

allopurinol; systemic

3.1

78.4

508

1919

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

16.7

78.0

127

ZX120

NOMESCO Finland

Intravenous

3.6

75.5

382

1198

L03AA14

ATC

lipegfilgrastim; parenteral

11.3

73.3

142

133

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

12.9

72.7

132

108

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

14.7

71.3

122

D69.4

ICD-10 Finland

Other primary thrombocytopenia

+∞

70.1

JN4AD

NOMESCO Finland

Body CT examination

3.8

69.7

321

927

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

62.5

848

4746

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

62.4

513

2219

H02AB02

ATC

dexamethasone; systemic

3.2

61.0

356

1232

A04AA02

ATC

granisetron; systemic, transdermal

4.1

60.3

251

658

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

16.4

60.1

B02BX05

ATC

eltrombopag; oral

+∞

58.6

A03FA01

ATC

metoclopramide; systemic, rectal

2.4

58.3

584

2805

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.5

57.6

157

257

L03AA13

ATC

pegfilgrastim; parenteral

5.7

57.2

173

323

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.3

55.5

221

555

J01MA12

ATC

levofloxacin; systemic

2.4

55.4

566

2735

A02BC02

ATC

pantoprazole; systemic

2.0

55.2

1579

11767

C03CA01

ATC

furosemide; systemic

2.1

53.1

820

4777

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.9

53.1

235

649

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

52.8

790

4539

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

51.6

600

3074

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

50.4

860

5192

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

21.2

49.8

JN6AD

NOMESCO Finland

CT of torso and neck

10.4

49.4

YNB10

NOMESCO Finland

Collection of stem cells for transplant

71.5

49.2

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

9.4

49.2

104

115

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.6

47.1

232

700

2875A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified

+∞

47.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.7

46.9

140

257

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

30.3

46.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

46.0

680

3841

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

12.4

45.4

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

40.9

44.8

C83.1

ICD-10 Finland

Mantle cell lymphoma

25.4

44.2

Z51.5

ICD-10 Finland

Palliative care

3.5

44.1

224

691

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

12.5

44.0

N02AA05

ATC

oxycodone; systemic

2.3

42.1

430

2045

ZXE00

NOMESCO Finland

One hour or less

1.8

41.9

995

6656

B01AB10

ATC

tinzaparin; parenteral

3.2

41.6

235

784

WW300

NOMESCO Finland

Transfer of autologic stem cells

22.7

41.5

A04AA01

ATC

ondansetron; systemic, rectal

3.3

41.4

226

736

D69.1

ICD-10 Finland

Qualitative platelet defects

+∞

40.7

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

109.4

39.8

3039

Kela drug reimbursment

+∞

38.6

1517

Kela drug reimbursment

+∞

38.6

D68.8

ICD-10 Finland

Other specified coagulation defects

46.8

37.9

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.7

37.1

118

ZXD05

NOMESCO Finland

Urgent procedure

1.8

36.3

779

4971

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

34.7

263

1057

TGC00

NOMESCO Finland

Bronchial lavation

4.9

34.6

117

248

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

34.5

561

3232

1XC02

NOMESCO Finland

13.8

33.6

B03XA02

ATC

darbepoetin alfa; parenteral

6.0

33.1

159

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

10.9

32.7

D69.0

ICD-10 Finland

Allergic purpura

73.2

31.9

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

31.6

167

530

WZC30

NOMESCO Finland

Teaching

2.2

31.5

354

1741

6BA02

NOMESCO Finland

24.9

31.4

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

14.2

31.1

AA1AD

NOMESCO Finland

CT of head and brain

1.9

31.0

587

3555

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

31.0

139

387

XX3DW

NOMESCO Finland

Time consuming IT work

2.4

30.6

289

1306

H02AB07

ATC

prednisone; oral

2.1

30.1

370

1893

R18

ICD-10 Finland

Ascites

6.0

29.5

142

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

12.6

29.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

29.3

213

834

2873A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]

+∞

29.2

R04.0

ICD-10 Finland

Epistaxis

2.6

29.2

221

885

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

28.9

286

1323

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

28.7

141

423

L01CB01

ATC

etoposide; systemic

17.0

28.4

ZX108

NOMESCO Finland

Inhalation

9.4

27.9

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

6.9

27.7

104

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.0

27.6

101

C03DA01

ATC

spironolactone; oral

2.2

27.1

294

1418

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

26.8

404

2236

D73.1

ICD-10 Finland

Hypersplenism

76.0

26.8

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.4

26.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.1

26.6

106

266

D61.9

ICD-10 Finland

Aplastic anaemia, unspecified

29.6

26.3

ED1AA

NOMESCO Finland

Mandipular X-ray examination

12.6

25.8

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

25.8

211

883

L04AX01

ATC

azathioprine; systemic

3.4

25.7

130

399

JMA10

NOMESCO Finland

Transabdominal total splenectomy

16.0

25.4

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

12.7

25.3

N02AX02

ATC

tramadol; systemic, rectal

1.6

25.1

951

6975

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

8.2

24.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.6

24.8

193

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

24.5

436

2554

B02AA02

ATC

tranexamic acid; systemic

2.1

24.1

313

1629

B01AB05

ATC

enoxaparin; parenteral

1.7

24.0

695

4732

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

23.9

251

1190

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.6

23.8

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

19.7

23.4

H02AB09

ATC

hydrocortisone; systemic

4.3

23.3

210

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.5

23.3

114

341

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

47.1

23.3

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

23.3

272

1353

J01DB01

ATC

cefalexin; oral

1.6

23.0

1844

16085

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

30.3

22.8

A07AA11

ATC

rifaximin; oral

40.5

22.7

122

Kela drug reimbursment

Aplastic anaemia

121.1

22.6

L04AD01

ATC

ciclosporin; systemic

4.8

22.4

159

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.4

22.2

126

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.8

22.1

157

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

22.0

128

436

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

6.1

22.0

100

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.3

21.8

200

D61.3

ICD-10 Finland

Idiopathic aplastic anaemia

221.8

21.6

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

21.2

342

1931

127

Kela drug reimbursment

Transplant complication

5.7

21.2

109

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

21.0

270

1397

J05AB11

ATC

valaciclovir; oral

2.0

20.9

303

1641

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

20.9

217

1022

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.6

20.9

155

613

B02BX04

ATC

romiplostim; parenteral

+∞

20.9

ZX131

NOMESCO Finland

Intrathecal

111.0

20.6

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

20.5

340

1936

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

13.8

20.0

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

19.0

19.9

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

58.0

19.9

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

15.4

19.7

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

5.9

19.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

19.6

805

5919

UJF32

NOMESCO Finland

Coloscopy

1.6

19.5

577

3915

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.9

19.4

118

414

K72.9

ICD-10 Finland

Hepatic failure, unspecified

10.7

19.4

TPX15

NOMESCO Finland

Removal of vascular injection port

15.7

19.3

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

13.4

19.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

19.1

184

836

TK800

NOMESCO Finland

Hemodialysis

4.1

18.9

189

K92.1

ICD-10 Finland

Melaena

2.6

18.9

145

584

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

18.8

164

711

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

13.5

18.7

A02BC01

ATC

omeprazole; systemic

1.6

18.7

627

4385

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.0

18.6

L04AA06

ATC

mycophenolic acid; systemic

4.9

18.4

124

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

15.2

18.4

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

18.4

605

4207

A41.8

ICD-10 Finland

Other specified sepsis

4.7

18.2

135

Z2221

NOMESCO Finland

Medical doctor

1.6

18.1

622

4367

A05AA02

ATC

ursodeoxycholic acid; oral

5.2

17.7

108

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

8.2

17.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

17.5

156

683

J01MA14

ATC

moxifloxacin; systemic

2.0

17.4

221

1135

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

17.4

863

6575

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

17.3

220

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

24.2

17.3

A46

ICD-10 Finland

Erysipelas

1.8

17.3

325

1923

Z3231

NOMESCO Finland

Registered nurse

1.6

17.2

622

4413

JN4CD

NOMESCO Finland

Very extensive body CT

2.8

17.2

113

415

N05CF01

ATC

zopiclone; oral

1.5

16.8

701

5139

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

35.3

16.7

WW200

NOMESCO Finland

Immunization

3.2

16.6

287

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

16.5

144

623

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

9.1

16.4

ZX112

NOMESCO Finland

Subcutaneous

3.6

16.4

215

N02BE01

ATC

paracetamol; systemic, rectal

1.5

16.2

1912

17239

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

7.1

16.1

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.1

16.0

183

899

R4110

NOMESCO Finland

Physiotherapy

1.5

16.0

582

4120

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

13.6

16.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

6.1

15.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.0

15.9

320

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

12.3

15.8

B01AA03

ATC

warfarin; systemic

1.6

15.8

472

3189

J01FF01

ATC

clindamycin; systemic

1.5

15.7

576

4084

D64.8

ICD-10 Finland

Other specified anaemias

4.3

15.7

138

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

15.6

352

2200

WX892

NOMESCO Finland

Monitored bed care

2.0

15.6

193

982

R60.0

ICD-10 Finland

Localized oedema

1.9

15.5

245

1363

TAB00

NOMESCO Finland

Lumbar puncture

2.7

15.4

108

416

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.3

15.3

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

15.3

356

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

20.2

15.1

A06AD11

ATC

lactulose; oral

1.7

15.1

339

2115

C91.4

ICD-10 Finland

Hairy-cell leukaemia

45.3

15.1

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

6.3

14.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

14.7

325

3038

Kela drug reimbursment

+∞

14.6

1516

Kela drug reimbursment

+∞

14.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

14.5

1061

8629

WX002

NOMESCO Finland

Sedation and analgesia

1.6

14.3

430

2900

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

14.3

129

568

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.6

14.3

186

R53

ICD-10 Finland

Malaise and fatigue

1.6

14.3

431

2910

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

13.4

14.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

5.5

14.2

L01BB02

ATC

mercaptopurine; oral

6.0

14.1

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

14.0

113

470

P01BA02

ATC

hydroxychloroquine; oral

2.0

14.0

174

884

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

17.6

13.8

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

53.6

13.8

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

53.6

13.8

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

5.4

13.6

WX110

NOMESCO Finland

Local anesthesy

1.4

13.5

1446

12517

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.0

13.4

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

13.3

364

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

5.2

13.2

J01MA02

ATC

ciprofloxacin; systemic

1.4

13.1

829

6535

SPAT1088

SPAT

Blood transfusion

8.3

13.0

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

16.8

13.0

N19

ICD-10 Finland

Unspecified kidney failure

2.6

12.9

359

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

50.3

12.8

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

12.8

151

754

Z2446

NOMESCO Finland

Social worker

2.1

12.8

150

744

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

11.6

12.8

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.4

12.8

103

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.2

12.6

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.1

12.6

119

WX882

NOMESCO Finland

High dependency care

2.8

12.5

281

C82.1

ICD-10 Finland

Follicular lymphoma grade II

6.7

12.5

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

8.7

12.5

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.7

12.4

150

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.9

12.4

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

11.7

12.3

J01CA04

ATC

amoxicillin; systemic

1.4

12.2

1744

15706

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

12.2

418

2897

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

37.7

12.2

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.4

12.1

TGD00

NOMESCO Finland

Needle biopsy of lung

7.0

12.1

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.6

12.0

149

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

18.1

12.0

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

18.1

12.0

K72.1

ICD-10 Finland

Chronic hepatic failure

21.4

12.0

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

11.9

102

438

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.8

11.9

A07AA09

ATC

vancomycin; oral

4.3

11.8

102

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

11.8

107

474

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

11.8

125

597

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.6

11.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

11.7

317

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

11.6

710

5530

N03AX16

ATC

pregabalin; oral

1.5

11.6

468

3364

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

11.6

500

3643

K29.6

ICD-10 Finland

Other gastritis

4.5

11.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.7

11.5

308

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

9.3

11.5

K92.0

ICD-10 Finland

Haematemesis

2.8

11.5

261

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.8

11.5

261

28710

ICD-8 Finland

Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)

+∞

11.5

D68.0

ICD-10 Finland

Von Willebrand disease

+∞

11.5

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.5

11.4

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

11.4

127

620

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

6.4

11.4

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.3

11.3

J02AC03

ATC

voriconazole; systemic

11.8

11.3

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

11.3

185

1045

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

11.3

298

D68.9

ICD-10 Finland

Coagulation defect, unspecified

35.2

11.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

11.2

288

1858

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.2

11.2

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

20.1

11.1

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

20.1

11.1

WX872

NOMESCO Finland

Intensive care

2.1

11.1

118

566

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

11.1

269

1709

I81

ICD-10 Finland

Portal vein thrombosis

10.1

11.0

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.9

11.0

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.4

10.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

10.9

218

1310

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

6.3

10.9

M05BA04

ATC

alendronic acid; oral

1.9

10.9

162

884

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

10.8

277

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

7.2

10.7

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

10.7

226

1379

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

28.1

10.7

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

17.9

10.7

WW409

NOMESCO Finland

Other aferesis

17.9

10.7

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

21.5

10.7

K76.9

ICD-10 Finland

Liver disease, unspecified

3.9

10.7

113

R72

ICD-10 Finland

Abnormality of white blood cells, not elsewhere classified

12.9

10.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

10.6

160

880

M10.9

ICD-10 Finland

Gout, unspecified

1.9

10.6

152

820

Z94.4

ICD-10 Finland

Liver transplant status

9.2

10.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

10.5

358

2478

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.3

10.5

N03AX14

ATC

levetiracetam; systemic

2.8

10.4

234

B34.9

ICD-10 Finland

Viral infection, unspecified

2.7

10.4

258

E0000UV

ATC

1.4

10.4

794

6402

130

Kela drug reimbursment

Malignant tumour

1.8

10.3

182

1053

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

10.2

361

2513

6753

FHL

Transabdominal splenectomy

23.4

10.2

C90.0

ICD-10 Finland

Multiple myeloma

4.1

10.2

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.3

10.2

WX402

NOMESCO Finland

General anaesthesia

1.5

10.1

329

2250

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

10.1

195

1159

J05AB01

ATC

aciclovir; systemic

1.5

10.1

404

2890

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

10.0

184

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

10.0

188

1109

Z3226

NOMESCO Finland

Physiotherapist

1.5

10.0

386

2739

212

Kela drug reimbursment

Gout

2.9

10.0

207

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

9.2

10.0

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

9.2

10.0

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.1

10.0

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.8

9.9

R31

ICD-10 Finland

Unspecified haematuria

1.7

9.9

225

1405

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.6

9.9

B02.9

ICD-10 Finland

Zoster without complication

2.0

9.9

122

621

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

9.8

152

842

A28

ICPC

Limited function/disability NOS

1.5

9.8

317

2165

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

20.1

9.8

JJC00

NOMESCO Finland

Allogenic transplantation of liver

10.7

9.8

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

9.8

268

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.0

9.7

178

R11

ICD-10 Finland

Nausea and vomiting

1.8

9.7

165

944

9983/3-C42.1

ICD-O-3

Myelodysplastic syndrome with excess blasts of bone marrow

55.2

9.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

9.6

280

1866

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

11.4

9.6

C07AG02

ATC

carvedilol; oral

1.9

9.5

132

702

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

9.5

120

617

S97

ICPC

Chronic ulcer skin

2.0

9.5

117

596

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.5

9.5

286

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

3.5

9.4

126

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

100.4

9.4

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

100.4

9.4

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

21.8

9.3

ZX121

NOMESCO Finland

Central venous catheter

8.1

9.3

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

9.3

549

4224

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.3

753

6101

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

9.2

117

603

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

9.1

399

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.2

9.1

424

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

8.3

9.1

B28

ICPC

Limited function/disability (B)

8.3

9.1

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.6

9.0

110

K76.6

ICD-10 Finland

Portal hypertension

36.8

9.0

C92.4

ICD-10 Finland

Acute promyelocytic leukaemia [PML]

36.8

9.0

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

8.9

181

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

8.9

146

825

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

8.9

155

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.2

8.8

139

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

8.8

452

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.7

8.7

215

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.7

717

5812

WF002

NOMESCO Finland

Radical radiotherapy

1.9

8.7

115

604

ZX080

NOMESCO Finland

Image guided radiotherapy

2.9

8.7

180

WNF00

NOMESCO Finland

Infection source and contact determination

6.6

8.6

SPAT1262

SPAT

Handing over of treatment supplies

1.4

8.6

379

2758

M35.1

ICD-10 Finland

Other overlap syndromes

6.2

8.6

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

11.6

8.6

D07AC01

ATC

betamethasone; topical

1.3

8.6

662

5313

D46.0

ICD-10 Finland

Refractory anaemia without ring sideroblasts, so stated

16.3

8.5

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

8.5

130

718

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

9.0

8.5

D69.8

ICD-10 Finland

Other specified haemorrhagic conditions

27.6

8.5

Z01.7

ICD-10 Finland

Laboratory examination

1.6

8.5

209

1334

9811/3-C42.1

ICD-O-3

B lymphoblastic leukemia/lymphoma, NOS, of bone marrow

90.3

8.4

D70.81

ICD-10 Finland

Neutropenia congenital

90.3

8.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

8.4

782

6445

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

8.4

189

1177

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

8.4

136

769

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

8.3

110

575

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

9.5

8.3

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.0

8.2

161

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

8.1

386

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.8

8.1

177

306

Kela drug reimbursment

Erythropoietin and darbepoetin

8.1

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

33.4

8.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.1

211

1369

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

8.0

158

948

UKC02

NOMESCO Finland

Cystoscopy

1.4

8.0

345

2497

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

8.9

8.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.0

588

4673

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

8.0

133

757

A03

ICPC

Fever

1.5

8.0

293

2053

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

8.0

257

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

8.0

160

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

4.0

7.9

SPAT1255

SPAT

Intravenous administration of medicine

1.8

7.9

141

819

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.8

7.9

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

7.9

483

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.9

7.9

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.1

7.9

129

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

4.1

7.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

7.9

796

6626

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

7.8

105

556

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

6.1

7.8

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.8

7.8

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.4

7.8

103

B82

ICPC

Anaemia other/unspecified

2.5

7.8

228

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

7.7

342

2490

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

7.7

153

921

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

7.6

354

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

7.6

153

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.3

7.6

311

D46.1

ICD-10 Finland

Refractory anaemia with ring sideroblasts

18.4

7.6

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

7.6

144

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

7.6

345

D61.0

ICD-10 Finland

Constitutional aplastic anaemia

25.1

7.6

E87.6

ICD-10 Finland

Hypokalaemia

2.4

7.6

245

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

7.5

202

A04AD12

ATC

aprepitant; systemic

2.9

7.5

148

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.9

7.4

508

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

7.4

280

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.5

7.4

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.8

7.4

164

WF004

NOMESCO Finland

Palliative radiotherapy

2.7

7.4

181

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

13.4

7.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.4

292

2079

J01AA02

ATC

doxycycline; systemic

1.3

7.4

1632

14964

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

7.3

131

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

+∞

7.3

28799

ICD-8 Finland

Purpura and other haemorrhagic conditions, Other and unspecified

+∞

7.3

C93.1

ICD-10 Finland

Chronic myelomonocytic leukaemia

+∞

7.3

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

+∞

7.3

D61.8

ICD-10 Finland

Other specified aplastic anaemias

+∞

7.3

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.6

7.3

C07AB07

ATC

bisoprolol; oral

1.3

7.2

968

8332

K70.0

ICD-10 Finland

Alcoholic fatty liver

5.2

7.2

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

15.8

7.2

I50.0

ICD-10 Finland

Congestive heart failure

1.7

7.2

150

916

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

7.2

138

822

N05BA04

ATC

oxazepam; oral

1.4

7.2

464

3605

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

7.2

153

941

3AC01

NOMESCO Finland

3.8

7.1

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

20.1

7.1

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.1

485

3802

SPAT1263

SPAT

Sampling

1.3

7.1

850

7210

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

5.0

7.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

7.0

126

739

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

7.0

456

3552

WX730

NOMESCO Finland

Conventional respirator

2.9

7.0

139

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

6.9

118

680

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.1

6.9

114

B73

ICPC

Leukaemia

13.8

6.9

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.9

6.9

141

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

6.8

164

1039

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

6.8

211

1426

TJA10

NOMESCO Finland

Laparocentesis

8.3

6.8

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

6.8

104

K76.7

ICD-10 Finland

Hepatorenal syndrome

11.0

6.8

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.7

6.7

167

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

6.7

107

600

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

6.7

237

A10AE04

ATC

insulin glargine; parenteral

1.6

6.7

183

1200

Z31.5

ICD-10 Finland

Genetic counselling

1.9

6.7

469

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

6.7

887

7606

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.0

6.7

117

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.4

6.6

232

A02BC05

ATC

esomeprazole; systemic

1.3

6.6

775

6543

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

6.6

223

1535

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

6.6

154

973

318

Kela drug reimbursment

Teriparatide

5.9

6.6

B99

ICPC

Blood/lymph/spleen disease other

5.5

6.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.4

6.6

214

ZX100

NOMESCO Finland

Oral

3.0

6.6

118

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

6.6

539

D53.1

ICD-10 Finland

Other megaloblastic anaemias, not elsewhere classified

10.0

6.5

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

6.5

220

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

6.4

392

D59.5

ICD-10 Finland

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

70.0

6.4

126

Kela drug reimbursment

Chronic coagulation defects

70.0

6.4

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

14.3

6.4

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.4

509

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.4

406

3144

I50

ICD-10 Finland

Heart failure

2.1

6.4

322

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

6.3

168

1096

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

2.5

6.3

180

L01AA01

ATC

cyclophosphamide; systemic

5.2

6.3

ZXA00

NOMESCO Finland

Right side

1.3

6.3

516

4150

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

6.3

536

M32

ICD-10 Finland

Systemic lupus erythematosus

18.1

6.3

B72

ICPC

Hodgkin Lymphoma

18.1

6.3

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

18.1

6.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

6.2

202

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

6.2

232

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.2

6.2

A10AE05

ATC

insulin detemir; parenteral

1.8

6.1

106

615

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

6.1

450

3562

B01AB04

ATC

dalteparin; parenteral

1.8

6.1

548

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.2

6.1

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.5

6.1

178

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

6.1

170

1126

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

6.0

110

647

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.8

6.0

131

L01XX05

ATC

hydroxycarbamide; oral

3.0

6.0

103

SPAT1234

SPAT

Support of social functional capacity

1.8

6.0

563

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

6.0

368

2833

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

385

429

10.32

321.77

6.7

5.0

iu/ml

4502.8

810.9

0.46

(21494434) Karyotype in Bone marrow

330

184

20.33

307.65

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

664

1249

6.75

307.65

2.2

1.8

g/l

1.2

1.4

1.68

625

1135

(3005719) IgG [Mass/volume] in Serum or Plasma

785

1589

6.59

307.65

3.7

2.7

g/l

10.0

10.5

1.51

735

1451

(3023520) Reticulocytes [#/volume] in Blood

949

1909

7.17

307.65

5.3

2.5

e9/l

77.0

69.5

2.80

740

1446

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1168

2482

7.60

307.65

7.6

3.9

u/l

275.7

245.8

3.11

1125

2346

(3045142) Bone marrow Pathology biopsy report

411

225

21.42

307.65

1.7

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

619

339

23.48

307.65

2.0

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

315

191

18.57

307.65

1.2

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1161

2564

7.25

307.65

5.1

2.5

1.9

1.8

3.59

1076

2265

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

467

526

10.55

307.65

2.4

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

436

603

8.45

306.62

3.6

2.7

g/l

3.3

3.6

3.35

419

572

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

559

1017

6.69

305.45

2.5

1.8

g/l

1.2

1.5

11.52

471

881

(42870588) Differential panel, method unspecified - Blood

1638

7426

4.13

279.40

12.5

5.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

811

2251

4.74

272.98

1.7

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

619

1433

5.32

258.54

1.5

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

1905

10108

4.11

246.27

13.4

5.8

2.4

2.9

17.90

1841

9394

(3019069) Monocytes/100 leukocytes in Blood

1910

10155

4.11

246.12

13.9

6.1

9.7

8.7

17.26

1844

9487

(3022096) Basophils/100 leukocytes in Blood

1870

9822

4.03

244.89

13.2

5.9

0.6

0.7

3.16

1812

9149

(3017181) Myelocytes/100 leukocytes in Blood

671

1741

4.82

243.31

7.3

3.9

1.0

0.9

0.67

414

510

(3002030) Lymphocytes/100 leukocytes in Blood

1928

10419

4.08

239.96

13.5

6.0

27.5

27.6

0.13

1865

9697

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

292

331

9.78

239.31

3.4

3.2

u/ml

22715.8

1923.7

0.50

(3018677) aPTT in Platelet poor plasma by Coagulation assay

961

3350

3.92

232.64

3.5

2.0

30.3

29.9

1.21

932

3244

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

197

126

16.80

231.38

2.7

2.4

—

(3011412) CD3 cells [#/volume] in Blood

224

186

13.06

227.01

3.3

2.3

e9/l

1.0

1.1

0.90

166

101

(21494815) CD4 cells/100 lymphocytes in Specimen

209

157

14.36

224.82

3.0

2.3

31.2

45.7

2.14

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

199

137

15.62

224.75

2.8

2.4

13.8

13.6

0.04

(1175426) CD3 cells/100 lymphocytes in Blood

201

141

15.34

224.70

2.8

2.4

74.2

72.2

0.64

193

132

(3001604) Monocytes [#/volume] in Blood

1924

10714

3.86

220.93

12.3

5.6

e9/l

0.6

0.97

1762

9190

(3018010) Neutrophils/100 leukocytes in Blood

1872

10251

3.78

220.44

12.4

5.8

56.4

57.4

2.51

1797

9580

(3006315) Basophils [#/volume] in Blood

1927

10758

3.86

220.02

12.3

5.6

e9/l

0.0

19.33

1761

9236

(3013115) Eosinophils [#/volume] in Blood

1963

11115

3.91

218.74

13.3

5.9

e9/l

0.1

0.2

33.58

1799

9696

(3012095) Magnesium [Moles/volume] in Serum or Plasma

969

3520

3.75

218.68

7.9

3.4

mmol/l

0.8

5.77

927

3303

(3002179) Metamyelocytes/100 leukocytes in Blood

607

1588

4.66

215.89

7.0

3.8

0.9

0.6

1.77

325

368

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

852

2864

3.90

215.26

1.7

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

619

1655

4.57

213.99

7.3

4.0

0.2

0.1

1.54

387

469

(3019198) Lymphocytes [#/volume] in Blood

1943

11021

3.82

213.73

12.6

5.7

e9/l

1.6

1.9

11.21

1799

9648

(3004809) Band form neutrophils/100 leukocytes in Blood

278

352

8.70

208.31

5.8

3.3

1.5

0.02

235

270

(3004588) Protein electrophoresis panel - Serum or Plasma

568

1509

4.51

196.82

2.2

2.4

—

(3025159) Blasts/100 leukocytes in Blood

565

1548

4.36

187.42

7.5

4.0

0.3

0.03

333

395

(21494814) CD8 cells/100 lymphocytes in Specimen

139

20.90

182.38

2.6

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

129

24.60

181.08

2.5

2.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2023

12492

3.57

178.80

24.3

8.6

e9/l

3.5

4.2

24.88

1877

10859

(3020630) Protein [Mass/volume] in Serum or Plasma

610

1827

4.03

178.55

2.8

2.7

g/l

65.4

66.4

1.86

567

1673

(46235355) HIV 1 and 2 tests - Meaningful Use set

893

3455

3.38

176.99

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

813

2977

3.49

175.91

3.2

2.6

25.7

22.8

4.32

752

2544

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1884

11212

3.32

175.73

15.1

6.1

umol/l

14.7

12.2

5.40

1825

10634

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

261

392

7.27

168.03

2.6

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

833

3177

3.36

167.77

3.2

2.5

g/l

2.2

2.3

4.89

787

2940

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

333

646

5.75

166.17

3.6

2.5

87.4

89.8

0.81

327

614

(3023368) Bacteria identified in Blood by Culture

1264

6199

2.98

163.22

9.0

4.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

298

531

6.19

162.48

2.6

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

263

415

6.92

161.59

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

865

3455

3.23

160.31

3.2

2.5

umol/l

13.7

13.0

1.63

825

3199

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

301

551

6.03

159.55

2.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

199

247

8.63

150.77

2.1

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

775

2994

3.24

150.73

9.4

6.0

mmol/l

1.1

1.0

0.66

735

2782

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

297

572

5.72

148.92

3.8

2.6

193.7

191.4

0.15

290

544

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

239

373

6.94

148.14

1.4

1.5

u/ml

107.0

123.2

0.52

(3007164) IgA [Mass/volume] in Serum or Plasma

926

4003

3.01

147.58

2.1

1.5

g/l

2.7

2.5

1.19

714

2395

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

219

316

7.46

145.85

2.0

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1608

9343

2.82

144.97

9.2

4.9

g/l

33.5

35.3

24.03

1525

8669

(4035726)

556

1805

3.63

142.14

1.8

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

139

113

12.92

142.02

2.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

139

113

12.92

142.02

2.3

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

245

413

6.43

140.83

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1099

5425

2.75

133.83

8.1

4.0

82.5

88.1

9.22

1061

5290

(3018418) pH of Serum or Plasma

1217

6337

2.69

133.02

8.8

3.9

7.4

4.34

384

1197

(40760892) CBC W Ordered Manual Differential panel - Blood

974

4560

2.79

131.01

10.4

4.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

582

2054

3.35

129.49

3.4

2.3

g/l

0.2

9.94

537

1918

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

379

6.36

128.07

1.9

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

238

428

6.01

127.89

6.0

3.5

56.5

57.8

0.56

238

428

(3036489) Thrombin time

324

771

4.65

126.50

3.5

2.2

22.2

21.5

1.28

306

689

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1618

9860

2.63

125.48

12.3

6.3

mmol/l

1.2

3.97

1520

8896

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1723

10837

2.67

124.93

13.6

7.0

mmol/l

1.2

2.84

1360

9131

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

196

297

7.04

124.55

1.9

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

138

136

10.65

124.18

1.6

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

222

389

6.13

122.43

1.3

u/ml

285.1

260.2

0.43

149

225

(3037522) Nuclear Ab [Titer] in Serum

675

2679

3.04

122.31

1.6

1.3

titre

684.2

507.3

1.19

180

566

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

145

9.98

118.59

2.0

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

285

643

4.84

118.58

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

129

125

10.79

117.41

2.1

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

148

175

8.90

116.25

2.1

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

472

1558

3.47

115.97

2.5

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

128

125

10.71

115.86

2.1

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

616

2412

3.02

113.47

5.8

2.8

umol/l

12.7

8.7

2.64

556

2110

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

816

3714

2.73

113.26

2.8

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

181

293

6.55

107.83

2.0

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1071

5666

2.49

107.70

5.0

2.8

umol/l

2209.2

6045.5

3.42

977

4892

(3032080) INR in Blood by Coagulation assay

1466

8928

2.43

107.61

15.0

9.8

inr

1.3

0.71

549

2515

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

193

337

6.10

106.60

1.9

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

232

482

5.18

106.12

5.9

2.9

umol/l

40.7

36.8

0.77

203

409

(3044640) Blood type and Crossmatch panel - Blood

1215

6857

2.42

105.24

5.8

2.4

—

(3021589) Normoblasts [#/volume] in Blood

1524

9501

2.41

105.24

25.3

9.4

e9/l

0.0

2.00

1307

7711

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1470

9116

2.37

101.37

4.1

2.8

ug/l

350.0

131.1

10.69

1385

8380

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1051

5657

2.42

100.08

2.8

2.2

mg/l

3.4

3.0

4.83

940

4796

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

142

192

7.76

99.71

1.5

1.2

—

(3037756) Immunofixation for Serum or Plasma

219

468

5.01

96.79

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

527

2053

2.95

96.61

11.3

7.4

mmol/l

10.5

10.1

0.53

502

1950

(3024471) HLA-A [Type]

14.19

95.75

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

156

248

6.62

94.44

7.0

3.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

102

10.78

93.24

5.1

3.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

266

685

4.20

92.95

2.9

3.5

ratio

2.3

1.8

0.23

(3034860) Kappa light chains.free [Mass/volume] in Serum

271

708

4.15

92.88

3.0

3.5

mg/l

253.2

59.4

0.48

205

571

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

270

709

4.12

91.87

3.0

3.5

mg/l

33.9

80.0

1.54

204

572

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

178

334

5.64

90.98

1.1

1.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

598

2574

2.71

90.17

2.3

1.7

—

(3048879) Bone marrow aspiration report

14.01

89.74

2.3

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

598

2586

2.69

89.25

2.3

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

235

568

4.44

89.15

2.7

1.5

g/l

0.2

7.44

212

543

(3016650) Hepatitis A virus Ab [Presence] in Serum

172

320

5.68

88.69

1.2

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

1150

6700

2.26

88.25

4.2

3.4

e6/l

136.5

82.4

0.73

961

5196

(3021960) Folate [Moles/volume] in Serum or Plasma

951

5135

2.32

87.38

1.8

1.6

nmol/l

18.4

20.4

4.38

867

4368

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

244

617

4.25

87.23

2.2

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

122

163

7.80

86.46

1.7

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

457

1752

2.94

85.49

10.8

3.7

mmol/l

1.2

1.84

427

1511

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

236

591

4.28

85.42

2.7

1.5

g/l

1.1

1.2

4.75

219

564

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

113

140

8.38

85.31

3.7

2.2

e6/l

562.2

524.3

0.17

117

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

204

459

4.73

84.57

1.7

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2158

16531

2.61

82.98

18.2

7.3

u/l

88.5

79.8

9.15

2093

15543

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1524

10120

2.18

82.33

9.2

4.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

222

546

4.34

82.22

1.4

1.2

titre

84.1

80.3

0.08

(3026782) Osmolality of Urine

835

4369

2.33

81.57

3.5

2.8

mosm/kgh2o

518.1

556.2

5.74

763

3727

(3030467) Casts [#/volume] in Urine by Automated count

1060

6124

2.21

81.41

4.1

3.3

e6/l

0.5

0.4

0.43

870

4667

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

306

950

3.51

81.38

2.5

1.9

ug/l

2.5

2.1

0.15

282

838

(40768795) Lymph node Pathology biopsy report

126

187

7.02

81.29

1.6

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1252

7745

2.16

80.61

5.0

3.8

e6/l

120.7

108.0

0.12

994

5559

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

137

225

6.36

80.24

2.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

805

4182

2.33

79.66

2.1

1.8

nmol/l

1261.3

1171.0

1.69

643

3146

(36304419) Bacteria [Presence] in Urine

1034

5957

2.20

79.55

4.0

3.2

—

(3042936) Bacteria identified in Isolate by Culture

655

3115

2.46

79.12

2.5

2.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

256

721

3.82

78.67

2.0

2.6

g/l

0.9

1.2

0.40

207

630

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

131

213

6.42

77.47

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

848

3.57

77.23

2.0

2.5

g/l

6.6

7.4

10.73

205

644

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

848

3.57

77.23

2.0

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

847

3.56

76.66

2.0

2.5

g/l

3.6

3.8

1.12

196

617

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

225

589

4.08

76.57

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1784

12809

2.19

76.23

9.8

4.9

mmol/l

6.7

6.8

0.95

1727

12000

(3034770) Mitochondria Ab [Titer] in Serum

215

546

4.20

76.22

1.4

1.2

titre

993.3

1227.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

108

146

7.67

75.71

3.7

2.1

e6/l

470.8

689.0

1.75

(3024932) HLA-DR beta [Type]

12.42

75.54

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

103

133

8.02

75.09

4.0

2.3

e9/l

0.2

0.02

116

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

153

298

5.39

74.93

1.5

1.2

u/ml

7.8

3.7

0.63

103

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

846

4596

2.23

74.32

2.7

1.7

mg/l

1.9

1.2

6.42

703

3517

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

28.29

74.04

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

227

622

3.90

72.42

7.3

4.9

mg/l

1.7

1.5

0.81

211

569

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

102

8.99

71.42

2.6

3.4

83.9

93.8

1.23

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

793

3.53

70.77

2.1

2.6

g/l

3.1

0.23

199

631

(40760888) Immunoglobulin light chains.free panel - Serum

206

536

4.08

70.59

3.1

3.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

164

362

4.76

69.42

1.5

1.2

u/l

113.2

37.9

3.70

151

314

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

512

2295

2.52

69.36

6.6

3.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

224

628

3.80

69.09

2.0

2.5

g/l

0.0

0.00

195

584

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

104

150

7.17

68.81

1.1

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

795

3.47

68.38

1.9

2.5

g/l

10.9

10.3

1.01

218

678

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

108

166

6.74

67.37

1.5

2.0

mg/l

5.0

4.7

0.13

101

159

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

370

1437

2.83

66.61

9.3

8.7

mmol/l

24.1

24.9

4.00

364

1430

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1105

6872

2.04

66.46

6.1

3.2

u/l

40.1

36.7

0.57

1051

6534

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

213

597

3.79

65.66

2.0

2.4

g/l

0.0

0.50

184

555

(3000850) Epithelial cells [#/volume] in Urine

831

4670

2.13

65.53

3.4

2.6

e6/l

6.4

5.4

0.90

769

4121

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1330

8877

2.00

65.04

2.4

2.0

pmol/l

90.9

94.2

1.77

820

4669

(3036481) Cortisol [Moles/volume] in Serum or Plasma

451

1965

2.56

64.50

2.2

2.1

nmol/l

350.9

371.6

1.30

430

1799

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1075

6705

2.01

63.33

3.7

2.6

u/l

54.7

57.8

1.14

990

6181

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

11.07

61.81

1.3

1.4

—

(3000012) Reticulocyte production index

109

7.92

60.93

2.4

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

205

592

3.67

60.41

2.0

2.4

g/l

0.0

0.00

184

554

(40758558) Short blood count panel - Blood

911

5454

2.02

59.39

15.6

6.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

159

392

4.25

58.43

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

133

285

4.86

58.26

1.5

1.2

u/ml

5.2

3.8

0.66

125

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

216

661

3.47

58.24

2.0

2.4

g/l

37.0

37.6

0.60

186

576

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

237

771

3.28

57.96

3.9

2.9

u/ml

0.3

0.4

3.59

146

431

(3000060) B lymphocytes [#/volume] in Blood

11.56

57.87

2.9

2.3

e6/l

198.4

244.2

0.23

(3027315) Oxygen [Partial pressure] in Blood

184

508

3.82

57.86

5.5

4.8

kpa

8.7

8.5

1.01

178

501

(3017354) Segmented neutrophils/100 leukocytes in Blood

118

231

5.30

57.36

6.3

3.2

53.7

58.2

0.95

150

(3012501) Base excess in Blood by calculation

183

507

3.80

57.25

5.5

4.8

mmol/l

2.2

2.7

1.54

127

345

(3013290) Carbon dioxide [Partial pressure] in Blood

183

508

3.79

57.08

5.6

4.8

kpa

4.7

5.1

8.40

177

502

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

123

252

5.07

56.78

3.0

1.6

—

(40758292) HTLV I+II Ab panel - Serum

17.07

56.61

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

881

5292

1.99

56.28

5.3

2.3

—

(40761536) Microorganisms panel - Urine sediment

415

1847

2.48

56.21

5.6

3.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

210

648

3.43

55.85

1.8

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

9.16

55.58

1.1

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1846

14207

1.97

55.27

6.0

4.5

e6/l

90.8

1505.0

2.38

215

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

9.49

54.63

3.0

2.3

32.2

27.7

1.15

(3013707) Erythrocyte sedimentation rate by Westergren method

1986

15707

2.04

54.58

6.0

4.0

mm/h

16.9

12.4

19.57

1875

14490

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

231

769

3.19

54.30

2.6

2.7

—

(1616796) Gas panel - Central venous blood

177

504

3.69

53.16

4.6

4.0

—

(40767503) Oxygen content in Capillary blood by calculation

167

461

3.80

52.47

3.6

2.5

14.7

16.0

3.01

236

(3006245) CD3-CD19+ cells/100 cells in Blood

8.98

52.37

3.0

2.5

11.0

9.9

0.25

(3042631) Mycobacterium sp identified in Specimen

132

308

4.46

52.04

2.3

2.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1100

7260

1.88

51.97

4.9

3.3

mmol/l

2.3

2.4

7.11

983

6311

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

9.88

51.96

1.0

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

110

225

5.06

50.85

3.2

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1885

14799

1.94

50.74

5.9

4.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

12.07

50.64

1.5

1.1

—

(3010421) pH of Blood

194

607

3.37

50.39

5.5

4.4

7.4

2.87

178

501

(3026008) Bacteria identified in Urine by Culture

1001

6466

1.88

50.14

3.7

3.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

321

1351

2.56

48.59

1.8

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

25.69

47.14

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

125

304

4.27

46.70

7.4

6.4

mg/l

11.5

11.9

0.41

118

282

(4212803)

20.85

46.13

1.1

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

285

1162

2.63

45.94

8.0

4.4

mmol/l

24.1

24.0

0.24

265

1050

(3021447) Carbon dioxide [Partial pressure] in Venous blood

442

2213

2.20

44.84

7.1

4.1

kpa

5.7

5.8

2.31

426

2143

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

132

347

3.95

44.39

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

439

2204

2.19

44.18

7.2

4.1

mmol/l

1.5

1.9

1.46

370

1743

(3028271) Lactate [Moles/volume] in Capillary blood

133

355

3.89

43.78

2.7

2.0

mmol/l

2.0

1.7

1.91

128

348

(4268621)

193

5.01

43.26

2.8

2.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

239

920

2.76

43.08

1.4

1.5

u/ml

6.3

20.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

25.27

42.56

1.2

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

6.88

42.48

31.4

27.5

ug/l

140.8

123.0

0.94

(3000991) Gas panel - Venous blood

399

1968

2.21

41.82

11.2

8.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1401

10381

1.74

41.71

6.4

5.0

estimate

0.0

0.50

435

1983

(40765096) Chromosome analysis panel by Banding

7.85

41.29

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1399

10382

1.73

41.24

4.9

3.6

estimate

0.0

0.00

431

1941

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.33

41.11

1.1

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1411

10507

1.73

40.98

5.0

3.7

estimate

0.0

0.12

419

1905

(3025941) Bacteria identified in Stool by Culture

272

1145

2.53

40.90

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

136

5.72

40.70

2.9

1.6

—

(3033799) Differential panel - Peritoneal fluid

8.79

40.56

3.2

2.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

124

5.94

40.12

3.2

2.7

32.9

39.7

0.92

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

14.58

39.96

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

161

5.22

39.71

1.4

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

955

6431

1.76

39.33

4.0

3.1

ng/l

2085.9

1544.7

2.66

860

5516

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

9.36

39.24

1.5

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.63

38.24

1.2

1.4

—

(44790047)

107

269

4.10

38.24

1.9

1.5

—

(44790048)

107

269

4.10

38.24

1.9

1.5

—

(44790049)

107

269

4.10

38.24

1.9

1.5

—

(44806118)

107

269

4.10

38.24

1.9

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

471

2554

2.03

38.24

2.0

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.10

38.00

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

139

422

3.42

37.77

4.5

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

599

3541

1.89

37.68

3.7

3.0

e6/l

2.3

2.1

0.28

357

1967

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

177

4.87

37.50

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.48

37.17

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

115

312

3.81

36.97

2.0

1.6

g/l

0.7

0.9

1.01

237

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

315

1479

2.28

36.97

6.5

4.5

mmol/l

1.8

1.7

0.29

240

1090

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

326

1556

2.25

36.78

6.4

4.6

kpa

5.0

5.1

1.81

307

1448

(3022493) Free Hemoglobin [Mass/volume] in Plasma

6.83

36.54

3.1

3.5

mg/l

65.3

61.9

0.17

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

20.20

36.34

2.4

5.3

—

(3009343) pH of Capillary blood

322

1539

2.24

36.18

6.5

4.6

7.4

2.59

169

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

12.15

35.93

1.3

1.0

67.9

68.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

15.67

35.72

4.2

2.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

175

630

2.90

35.65

6.4

5.1

kpa

8.2

8.3

0.34

161

583

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

159

543

3.05

35.58

1.9

2.0

mg/l

10.5

11.7

0.90

151

496

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

8.93

35.46

1.3

1.1

78.3

83.6

0.32

(3008536) Aspergillus sp Ab [Presence] in Serum

9.47

35.38

3.5

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

11.36

35.37

1.8

2.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

25.23

35.36

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

730

4665

1.78

35.31

1.9

1.7

pmol/l

474.8

24715154.9

3.29

617

3856

(3015235) Bicarbonate [Moles/volume] in Capillary blood

166

590

2.93

34.60

5.6

3.3

mmol/l

24.0

24.8

1.35

150

514

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

191

734

2.73

34.40

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.91

34.39

1.8

2.3

u/ml

350.0

34635.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1143

8303

1.66

34.25

5.6

3.8

ng/l

45.7

55.1

0.49

934

5893

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

187

715

2.74

34.01

1.7

1.5

titre

448.9

249.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

381

1992

2.06

33.90

9.6

7.4

mmol/l

1.5

1.4

1.32

368

1917

(3003694) ABO and Rh group [Type] in Blood

868

5886

1.70

33.68

1.8

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

8.39

33.00

1.2

1.0

82.2

83.6

0.08

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

158

563

2.92

32.77

1.4

1.3

iu/ml

21.3

18.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

206

4.28

32.77

4.1

2.6

—

(3015736) pH of Urine

1111

8078

1.64

32.72

4.5

3.4

—

5.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

11.47

32.71

1.3

1.1

62.1

82.0

—

(3029937) Albumin [Presence] in Urine by Test strip

834

5637

1.70

32.52

5.3

4.0

estimate

0.0

1.28

398

1891

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1168

8615

1.63

32.37

2.7

2.2

nmol/l

75.6

77.0

0.90

1060

7664

(3022217) INR in Platelet poor plasma by Coagulation assay

498

2904

1.88

32.14

24.0

26.6

inr

1.5

1.4

0.51

423

(3014576) Chloride [Moles/volume] in Serum or Plasma

485

2807

1.89

32.03

10.2

7.0

mmol/l

104.5

104.4

0.25

468

2742

(3024354) Oxygen [Partial pressure] in Venous blood

353

1831

2.07

31.99

6.6

3.6

kpa

4.7

4.6

0.35

338

1770

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

103

287

3.69

31.87

1.2

1.1

g/l

1.6

1.5

0.63

261

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

165

613

2.80

31.68

2.7

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

4.23

31.19

3.6

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

4.23

31.19

3.6

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

4.23

31.19

3.6

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

5.68

31.01

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

224

4.03

30.94

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

629

3979

1.76

30.89

3.9

3.0

mmol/l

2.5

0.80

556

3485

(3041096) Erythrocytes [Presence] in Urine by Automated

818

5567

1.68

30.73

5.0

3.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

183

729

2.62

30.66

1.4

1.2

u/ml

1.1

0.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

370

1991

2.00

30.19

3.1

2.4

u/l

31.4

62.7

0.71

318

1696

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

164

4.55

30.18

1.3

1.2

titre

300.0

168.8

0.40

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.75

30.17

1.8

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

601

3776

1.76

30.13

3.5

2.9

e6/l

1.2

1.1

0.39

362

2194

(3006922) Hepatitis E virus Ab [Presence] in Serum

122

5.18

29.97

1.1

1.0

—

(4062490)

195

4.20

29.81

1.6

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

7.20

29.69

1.9

1.5

g/l

9.4

12.6

1.19

(3024139) IgG subclass 3 [Mass/volume] in Serum

194

4.17

29.15

1.6

1.4

g/l

0.5

0.4

0.66

134

(3027135) IgG subclass 1 [Mass/volume] in Serum

194

4.17

29.15

1.6

1.4

g/l

6.8

7.0

0.19

136

(3028192) IgG subclass 2 [Mass/volume] in Serum

194

4.17

29.15

1.6

1.4

g/l

2.8

2.9

0.29

136

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.22

28.82

2.9

2.6

—

(40768441) Liver Pathology biopsy report

151

4.60

28.53

2.0

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.71

28.50

3.1

1.9

e6/l

4160.9

24836.8

0.44

(3023419) Bacteria identified in Sputum by Culture

288

3.49

28.01

2.0

2.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

118

5.09

28.01

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

8.47

27.89

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

9.05

27.72

1.4

1.3

—

(3000494) Fungus identified in Specimen by Culture

426

2475

1.86

27.45

2.0

1.4

—

(3003396) Base excess in Arterial blood by calculation

438

2570

1.84

27.34

9.7

7.6

mmol/l

0.9

1.1

0.29

341

2006

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.77

27.27

4.8

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.77

27.27

4.8

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2365

21310

1.98

27.16

37.8

14.7

mg/l

24.0

25.0

0.79

2140

16965

(3044007) Cell count panel - Peritoneal fluid

7.24

27.14

3.2

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

5.64

26.64

4.8

1.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

436

2575

1.83

26.59

9.6

7.6

kpa

4.9

5.1

2.58

415

2455

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.96

26.52

3.1

2.3

e6/l

374.4

803.9

1.44

(3027801) Oxygen [Partial pressure] in Arterial blood

435

2576

1.82

26.27

9.6

7.6

kpa

12.5

12.1

0.71

414

2457

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

273

1384

2.08

26.09

2.1

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

197

3.94

26.09

2.3

1.4

iu/ml

28.7

28.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

118

4.91

26.02

1.1

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

115

4.95

25.80

4.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

115

4.95

25.80

4.4

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

115

4.95

25.80

4.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

115

4.95

25.80

4.4

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

904

6526

1.58

25.77

2.7

2.1

u/l

335.0

235.0

0.46

851

6125

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1650

13614

1.56

25.77

5.4

3.1

u/l

71.5

50.7

11.54

1550

12628

(3006184) Hemoglobin [Mass/volume] in Capillary blood

133

494

2.78

25.54

3.0

2.2

g/l

115.1

128.7

6.67

111

363

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.94

24.28

1.4

—

(40768797) Stomach Pathology biopsy report

475

2949

1.74

24.27

1.3

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.64

24.21

1.4

g/l

14.5

25.2

2.98

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

6.20

24.10

5.3

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

379

2220

1.82

23.55

3.9

4.1

ug/l

21.4

24.2

0.10

314

1827

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1051

7979

1.52

23.28

5.3

3.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

4.65

23.14

2.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.24

22.69

2.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.24

22.69

2.7

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

116

4.64

22.67

2.5

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2010

17576

1.58

22.30

46.0

17.7

14.6

13.7

74.34

1987

17164

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

192

902

2.22

22.23

2.0

1.8

u/l

44.7

38.3

2.25

179

787

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

206

3.62

22.22

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

105

373

2.89

21.92

1.7

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

114

4.54

21.27

1.3

1.2

ratio

1.2

1.1

1.21

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

6.04

21.23

1.2

1.1

—

(4281824)

189

3.67

21.18

1.4

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

169

769

2.28

21.13

2.7

2.2

ug/l

450.2

497.8

0.11

156

720

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

394

2408

1.75

21.05

2.2

1.8

1.5

2.66

319

2109

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

167

3.84

21.00

1.1

1.0

mg/l

291.0

286.4

0.13

150

(3016502) Oxygen saturation in Arterial blood

380

2311

1.75

20.63

10.5

8.0

95.3

95.5

0.18

364

2224

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.85

20.56

1.2

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

327

2.94

20.39

1.3

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

204

3.50

20.32

1.3

1.2

u/l

82.9

57.7

0.56

140

(3019832) Treponema pallidum Ab [Presence] in Serum

295

1674

1.86

20.16

1.5

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

118

466

2.60

20.12

2.8

1.5

e6/l

62.1

30.1

0.26

361

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

118

466

2.60

20.12

2.9

1.6

e6/l

364.7

748.2

0.57

102

379

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

225

1190

1.97

18.99

11.1

10.0

mmol/l

24.0

24.2

0.73

214

1112

(3024928) Oxygen saturation in Venous blood

116

469

2.54

18.86

6.6

3.3

—

(3042733) HLA Ab [Presence] in Serum

5.52

18.84

3.1

4.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

128

4.04

18.36

1.6

1.5

u/l

4.3

6.7

0.59

(3013139) Helicobacter pylori Ag [Presence] in Stool

245

1354

1.89

18.13

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

141

638

2.28

17.87

3.8

3.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

342

2113

1.71

17.39

11.4

8.5

g/l

112.9

121.8

11.02

330

2032

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

118

503

2.41

17.15

1.6

1.2

u/ml

3.6

3.5

0.01

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

389

2.60

17.08

1.6

1.2

u/ml

54.6

47.3

0.17

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

109

449

2.49

17.06

3.2

3.4

u/ml

353.0

942.9

0.47

417

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

119

511

2.39

17.02

1.6

1.2

u/ml

20.6

8.8

0.48

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

481

2.43

16.95

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

481

2.43

16.95

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

288

2.87

16.94

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

107

439

2.50

16.89

3.0

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

8.81

16.78

1.5

1.9

—

(40768804) Tissue Pathology biopsy report

1060

8446

1.42

16.64

2.3

2.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

123

547

2.31

16.25

1.6

1.2

u/ml

37.8

38.3

0.01

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

277

1650

1.76

16.01

5.9

4.2

ng/l

103.8

92.4

1.04

242

1438

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

105

439

2.45

15.93

1.8

1.7

—

(3022313) Gas panel - Capillary blood

210

1151

1.90

15.92

7.4

4.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

196

1053

1.93

15.78

6.3

2.9

1.2

0.15

196

1046

(3017732) Neutrophils [#/volume] in Blood

246

1422

1.80

15.74

3.3

3.2

e9/l

3.7

4.2

1.63

182

1106

(3009871) Measles virus Ab [Titer] in Serum

5.63

15.55

1.7

1.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

6.46

15.37

1.1

1.3

titre

60.3

159.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

227

3.00

15.29

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

295

2.73

15.10

1.6

1.5

g/l

29.8

32.4

1.11

266

(3003181) Sodium [Moles/volume] in Urine

395

2.48

15.09

1.9

1.4

mmol/l

65.6

61.3

0.33

320

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

14.07

15.05

1.4

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.54

14.92

2.3

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.22

14.85

1.4

1.2

28.0

15.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

155

785

2.03

14.77

3.6

3.3

u/ml

551.4

5251.4

0.74

130

675

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

614

4503

1.47

14.69

1.4

1.3

u/ml

3.5

1.4

1.41

143

1142

(3019550) Sodium [Moles/volume] in Serum or Plasma

2354

21925

1.63

14.51

38.7

17.2

mmol/l

139.2

139.6

14.29

2320

21358

(3012441) Differential panel - Pleural fluid

229

2.93

14.46

1.6

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2358

21980

1.63

14.39

39.5

17.3

mmol/l

4.0

0.01

2318

21381

(3004119) Hemoglobin [Mass/volume] in Venous blood

237

1391

1.77

14.38

6.1

3.4

g/l

116.6

128.5

10.71

232

1352

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

176

944

1.93

14.24

3.6

1.9

—

(3019060) Gas panel - Arterial blood

252

1511

1.74

14.19

6.6

4.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

112

511

2.24

13.96

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

315

2.59

13.80

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

252

2.78

13.78

1.5

1.8

—

1253.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

130

636

2.10

13.61

1.5

1.6

iu/ml

1.8

10.9

0.45

125

(21491868) Cryoglobulin [Mass/volume] in Serum

4.35

13.58

1.2

g/l

0.1

—

(3020393) Adenovirus Ag [Presence] in Stool

7.19

13.55

1.6

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

5.46

13.53

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

580

4269

1.46

13.47

4.4

3.9

ng/l

419.0

700.9

0.60

470

3406

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

362

2.45

13.39

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

223

2.87

13.34

2.9

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

257

2.73

13.29

1.1

—

(3022145) Colonoscopy Study observation

349

2315

1.58

13.24

1.4

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

105

477

2.25

13.24

2.8

1.3

mmol/l

3.8

0.03

445

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

410

2.34

13.04

1.6

1.2

u/ml

4.7

5.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

100

451

2.26

12.84

2.9

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

127

630

2.07

12.83

1.4

ug/g

260.2

281.0

0.48

370

(3039162) Centromere protein B Ab [Units/volume] in Serum

240

2.75

12.74

1.6

1.2

u/ml

52.6

65.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

11.87

12.64

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

174

3.03

12.19

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

109

3.62

12.15

1.3

1.1

u/l

27.0

32.2

0.28

(3034426) Prothrombin time (PT)

4.63

12.12

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

358

2449

1.53

11.79

2.5

2.3

ug/g

159.9

137.3

0.51

292

1934

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.94

11.68

3.8

2.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2143

19788

1.42

11.49

32.7

13.7

ml/min/173m2

78.5

79.8

1.67

1896

16303

(3013293) Extractable nuclear Ab [Presence] in Serum

7.12

11.42

2.1

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

279

2.51

11.33

1.2

1.1

107.1

115.2

0.94

255

(3013512) EKG study

787

6268

1.36

11.28

4.9

4.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

113

565

2.04

11.21

1.3

miu/ml

199.3

234.8

0.41

247

(3011397) Hemoglobin [Presence] in Urine by Test strip

640

4938

1.39

11.14

4.1

3.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

25.12

11.13

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1776

15953

1.34

11.00

4.2

3.8

pmol/l

14.8

0.20

1624

14411

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.44

10.73

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

134

3.17

10.70

1.7

1.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

21.54

10.67

1.1

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

153

862

1.82

10.66

2.3

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

172

1005

1.76

10.61

8.1

5.2

mmol/l

24.8

24.7

0.30

163

946

(3016750) Collection duration of Urine

135

3.14

10.57

2.1

2.0

min

537.4

496.7

1.57

(3051651) Icteric interference index of Serum or Plasma

130

3.19

10.56

4.4

3.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

229

2.61

10.55

1.7

2.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

151

3.01

10.54

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

151

3.01

10.54

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

151

3.01

10.54

1.1

—

(3028433) Virus identified in Specimen by Culture

4.01

10.49

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

223

1403

1.64

10.47

9.9

7.1

mmol/l

24.8

24.5

0.42

204

1309

(3018405) Lactate [Moles/volume] in Arterial blood

144

801

1.84

10.46

4.7

3.8

mmol/l

1.4

0.07

136

792

(3024891) Influenza virus A+B Ag [Presence] in Specimen

113

580

1.99

10.44

1.3

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

224

1414

1.64

10.38

12.1

9.3

1.5

1.3

1.08

219

1406

(3009542) Hematocrit [Volume Fraction] of Blood

2089

19299

1.38

10.37

35.1

15.8

37.5

39.6

18.02

1409

13551

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.96

10.19

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.96

10.19

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.96

10.19

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.34

10.05

1.2

1.4

—

(40768806) Pleura Pathology biopsy report

241

2.52

10.03

1.7

1.6

—

(3017704) Immunofixation for Urine

140

3.03

9.96

1.9

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

187

1139

1.69

9.95

2.3

2.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

221

1408

1.62

9.87

12.5

9.5

0.7

0.74

216

1401

(3002256) Pathology report gross observation

382

2750

1.45

9.71

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.03

9.57

1.5

3.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

254

2.43

9.47

1.3

—

(4306422)

279

2.36

9.44

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

184

2.69

9.39

1.2

1.1

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

286

2.34

9.38

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

256

2.42

9.31

3.7

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

116

628

1.89

9.20

1.3

1.1

—

(3044889) 12 lead EKG panel

1655

14886

1.30

9.19

5.2

3.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

258

2.40

9.16

3.7

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

115

622

1.89

9.15

1.3

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

116

3.13

9.07

1.6

u/field

2.0

2.5

0.23

(3024522) Salmonella sp identified in Specimen by Organism specific culture

260

2.38

9.01

3.7

1.4

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.20

8.98

1.7

1.5

mg/l

1.9

5.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

261

2.37

8.94

3.7

1.4

—

(3047189) Immunofixation for 24 hour Urine

102

3.26

8.89

1.3

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

256

2.37

8.85

3.8

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

250

2.39

8.84

6.4

6.7

mmol/l

9.0

7.3

0.33

209

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.50

8.83

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

258

2.36

8.70

3.7

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

115

633

1.85

8.68

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

271

2.32

8.67

1.5

1.4

e6/l

1222.4

1609.1

0.66

192

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

350

2.15

8.57

3.8

3.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

105

3.17

8.50

1.2

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

6.87

8.44

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

213

2.47

8.40

4.2

3.5

—

(3004775) Volume in Urine collected for unspecified duration

178

2.61

8.35

2.1

2.2

767.0

614.1

1.23

114

(3035880) pH of Pleural fluid

134

2.86

8.22

1.6

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

4.37

8.14

3.8

3.0

u/l

40.9

40.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.40

8.07

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2365

22541

1.44

7.94

23.4

10.3

u/l

28.0

26.4

1.87

2313

21706

(3020891) Body temperature

148

902

1.68

7.90

5.9

4.6

—

(3037121) Protein [Mass/volume] in Urine

136

813

1.71

7.80

3.7

3.6

g/l

0.3

0.14

339

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2362

22521

1.43

7.78

40.4

17.1

umol/l

86.1

79.5

8.28

2362

22511

(3028308) Erythrocytes [#/volume] in Pleural fluid

241

2.31

7.69

1.5

1.4

e6/l

49302.6

85624.6

0.44

140

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

187

1220

1.57

7.59

15.6

10.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.36

7.58

3.8

4.2

—

(3019225) pH of Specimen

305

2206

1.43

7.50

8.6

4.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

191

1266

1.55

7.24

1.4

1.3

u/ml

405.9

228.9

1.09

167

1163

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

7.72

7.12

1.1

4.7

—

(3019977) pH of Arterial blood

117

2.84

7.11

5.1

2.9

7.5

7.4

2.01

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.27

7.10

1.0

1.1

—

(40761511) CBC panel - Blood by Automated count

2315

22063

1.38

7.04

34.8

13.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

434

3365

1.35

7.01

1.3

1.2

iu/ml

42.9

35.9

0.26

128

1056

(40768446) Kidney Pathology biopsy report

3.16

6.98

1.8

1.7

—

(3000330) Specific gravity of Urine by Test strip

169

1101

1.57

6.92

4.4

3.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.27

6.83

1.0

1.1

miu/ml

1100.7

1545.1

1.54

(3033705) Calcium.ionized [Moles/volume] in Venous blood

274

2.14

6.81

4.0

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

248

2.20

6.80

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1436

12938

1.24

6.78

3.4

2.9

—

(3036603) Volume of Urine

138

2.63

6.71

1.4

2029.7

1845.3

0.34

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

240

1703

1.45

6.55

3.3

2.8

ml/min/173m2

58.5

65.0

1.60

125

677

(3027456) Digoxin [Moles/volume] in Serum or Plasma

479

1.82

6.34

3.0

3.2

nmol/l

0.8

0.58

367

(3009214) Lutropin [Units/volume] in Serum or Plasma

546

1.77

6.32

1.5

1.4

u/l

12.0

8.9

1.08

445

(3004451) EKG impression Narrative

108

2.80

6.31

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2050

19284

1.27

6.30

5.1

4.6

mu/l

2.0

0.02

1898

17553

(3045788) Cell count panel - Pleural fluid

220

2.20

6.10

1.7

1.4

—

(3014271) Vancomycin [Susceptibility]

116

2.69

6.08

3.3

2.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

266

1957

1.40

5.94

2.3

2.4

ug/l

8.3

7.3

0.38

233

1716

(3046861) Legionella sp Ag [Presence] in Urine

11.15

5.79

1.0

—

(3049717) Cytology report of Urine Cyto stain

140

912

1.56

5.78

2.3

2.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.02

5.74

1.0

1.3

u/l

22.5

17.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.66

5.73

1.3

1.0

—

(40768443) Skin Pathology biopsy report

136

885

1.57

5.65

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

104

1647

0.62

5.56

2.0

1.7

—

(36660697) Celiac disease serology panel - Serum

221

1598

1.42

5.46

1.2

—

(3012516) Albumin [Mass/volume] in Urine

753

6445

1.23

5.44

3.7

3.3

mg/l

1030.7

302.5

2.12

530

4196

(3011648) Oxygen content in Venous blood

179

2.25

5.42

12.0

3.3

10.0

11.2

1.46

179

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.13

5.36

1.9

1.6

4.7

7.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

787

6788

1.23

5.25

4.8

4.0

mg/mmol

12.5

11.6

0.11

532

4382

(3045414) Leukocytes [Presence] in Urine

141

943

1.52

5.20

1.9

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.65

5.20

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.65

5.20

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.65

5.20

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.65

5.20

1.1

—

(3023410) Appearance of Cerebral spinal fluid

225

2.06

5.02

4.8

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

793

6874

1.22

5.00

4.0

3.2

mmol/l

7.2

7.6

1.99

669

5795

(3043410) Blood group antigens tested for on Red Blood Cells

2.97

4.98

3.0

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

3.67

4.92

1.7

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

568

1.64

4.79

5.2

4.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

11.46

4.78

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.03

4.78

1.4

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.70

4.64

9.6

6.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

2.36

4.57

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

105

678

1.57

4.57

5.0

3.9

mmol/l

3.9

0.37

633

(3011325) HIV 1+2 Ab [Presence] in Serum

10.03

4.52

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

228

1.99

4.50

1.8

2.7

umol/l

13.3

10.6

0.29

158

(3004616) Nuclear Ab [Presence] in Serum

251

1.93

4.40

1.5

1.2

—

(3022621) pH of Urine by Test strip

192

1411

1.39

4.37

2.9

3.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.91

4.28

1.5

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

3.62

4.20

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

132

915

1.47

4.15

6.6

3.2

u/ml

84.7

51.8

0.82

126

877

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

2.00

4.07

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.02

4.06

6.0

5.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.02

4.06

6.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.51

4.04

1.0

1.1

iu/ml

388.6

200.7

0.60

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

603

1.56

4.02

2.4

2.3

u/l

7637.0

3866.5

0.39

247

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

10.02

4.01

1.0

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

110

741

1.51

4.00

1.4

iu/l

30.7

26.9

0.46

621

(3021788) Differential panel - Synovial fluid

386

1.70

3.98

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

282

1.82

3.98

1.5

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

158

2.10

3.88

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

119

2.28

3.87

3.0

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

657

1.53

3.87

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

250

1954

1.31

3.81

3.4

2.9

ng/l

297.3

210.0

2.08

232

1788

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.80

1.5

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

146

1050

1.41

3.80

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

153

2.10

3.78

2.2

1.5

promille

1.1

1.2

0.16

116

(3020961) Endomysium IgA Ab [Titer] in Serum

135

962

1.42

3.70

1.2

1.1

titre

128.3

167.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

128

907

1.43

3.63

9.4

5.7

0.9

0.13

118

847

(3017569) Oxygen content in Arterial blood

110

2.28

3.61

2.9

2.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

143

2.11

3.59

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

129

919

1.42

3.56

8.8

5.7

1.7

1.6

0.46

118

857

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

7.79

3.56

2.7

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

185

1.96

3.53

2.8

2.2

u/field

2.0

1.9

0.02

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

144

2.10

3.53

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.56

3.48

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.43

3.47

1.0

—

(3044927) Protein electrophoresis panel - Urine

245

1.81

3.40

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

107

2.25

3.38

1.5

1.8

—

(3035933) Granulocytes/100 leukocytes in Blood

2.58

3.38

1.0

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.51

3.37

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.01

3.36

1.7

1.0

—

(4211845)

101

2.29

3.36

2.8

2.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

3.25

3.34

1.6

2.8

—

(3014051) Protein [Presence] in Urine by Test strip

502

1.55

3.31

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1105

0.65

3.29

1.6

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.68

3.22

1.2

ug/l

436.1

67.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

103

2.24

3.22

3.5

3.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

3.34

3.19

7.5

4.2

umol/l

46.2

41.0

0.33

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.38

3.18

2.7

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

130

2.09

3.18

2.5

3.5

mu/l

19.0

28.9

0.59

123

(3006270) Folate [Moles/volume] in Blood

179

1.91

3.14

1.3

1.2

nmol/l

325.7

368.6

0.54

154

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.38

3.06

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

577

1.49

3.05

1.3

1.4

—

(3014891) Appearance of Pleural fluid

3.46

3.04

1.4

1.5

—

(3007461) Platelets [#/volume] in Blood

2416

23594

1.26

2.98

56.5

21.4

e9/l

162.0

247.8

318.95

2370

22956

(3024731) MCV [Entitic volume]

2417

23605

1.26

2.98

56.2

21.4

92.2

91.0

18.31

2392

23232

(3035941) MCH [Entitic mass]

2417

23606

1.26

2.97

56.1

21.3

30.6

30.3

7.61

2392

23230

(3010813) Leukocytes [#/volume] in Blood

2418

23617

1.26

2.97

56.4

21.5

e9/l

6.5

6.8

2.17

2371

22905

(3026361) Erythrocytes [#/volume] in Blood

2417

23608

1.26

2.95

56.4

21.4

e12/l

4.2

4.5

108.75

2369

22901

(21494755) Public health laboratory ask at order entry panel

124

1666

0.73

2.93

1.2

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.72

2.92

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

2.01

2.90

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2417

23615

1.25

2.90

56.8

21.5

g/l

125.3

135.2

125.03

2391

23241

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.10

2.88

1.4

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

382

3247

1.21

2.84

1.3

1.2

u/ml

15.1

12.1

0.26

117

1239

(3045424) Erythrocytes [Presence] in Urine

346

1.60

2.80

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

231

1.74

2.80

3.6

3.8

—

(3006462) Nitrate [Presence] in Urine

2.18

2.67

3.1

2.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.47

2.62

1.6

1.4

ug/l

9.9

8.9

0.27

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.68

2.59

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.68

2.59

1.0

—

(44806071)

3.61

2.57

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.01

2.56

9.0

4.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.46

2.54

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.46

2.54

1.8

3.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.38

2.47

1.1

—

(3047181) Lactate [Moles/volume] in Blood

707

1.39

2.44

11.2

6.7

mmol/l

1.4

1.3

0.19

617

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.09

2.43

1.1

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.01

2.40

1.2

—

(40761535) Cells panel - Urine sediment

221

1812

1.24

2.36

4.3

3.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

161

1.81

2.35

1.1

mg/l

62.8

40.6

1.02

134

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.23

2.27

2.1

2.5

—

(4198724)

2.23

2.27

2.2

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.62

2.27

1.3

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.62

2.27

1.2

1.0

—

(3019174) dRVVT (LA screen)

3.90

2.25

1.3

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

5.56

2.21

2.0

1.0

—

(4027681)

121

1.91

2.20

1.4

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

517

1.42

2.20

1.6

1.7

e6/l

21547.1

16053.4

0.41

373

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

195

1.70

2.19

1.4

30.9

27.3

0.18

118

(3008295) Osmolality of Serum or Plasma

249

1.62

2.19

2.0

1.4

mosm/kgh2o

279.3

279.7

0.04

182

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.01

2.14

10.2

11.9

mmol/l

9.6

6.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

197

1.68

2.12

1.4

ug/l

3.5

2.9

0.46

174

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

520

0.61

2.09

1.3

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.01

2.07

2.4

2.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.03

2.05

1.2

1.1

ng/l

2697.9

295.3

—

(3050794) Legionella sp Ab [Presence] in Serum

3.51

2.05

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

147

1.78

2.02

2.6

1.5

g/l

0.9

1.0

0.72

147

(3002619) Bacteria identified in Specimen by Culture

2.64

2.01

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

347

1.48

1.92

1.6

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.25

1.90

8.9

6.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

558

1.37

1.90

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

182

1.66

1.85

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.17

1.82

1.0

1.4

umol/24h

334.2

374.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

320

1.48

1.79

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

488

1.38

1.78

4.6

3.6

mg/l

30.7

28.3

0.19

310

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.17

1.77

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

3.34

1.74

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

132

1.75

1.73

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

915

0.74

1.73

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.92

1.72

1.7

1.5

—

(4010399)

180

1500

1.21

1.72

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.92

1.70

1.2

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

156

1.67

1.69

1.1

mg/l

358.6

276.4

0.61

136

(3028707) Methadone [Presence] in Urine by Screen method

308

1.47

1.68

8.3

2.3

—

(3019150) Specific gravity of Urine by Refractometry

507

4593

1.13

1.67

5.6

4.0

kg/l

1.0

0.11

693

(3029075) Extractable nuclear Ab panel - Serum

2.07

1.59

1.2

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

551

1.33

1.58

2.8

2.3

ug/min

186.7

105.0

0.78

340

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.86

1.50

2.3

3.0

u/field

0.0

0.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

385

3454

1.13

1.49

1.6

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.88

1.44

2.0

2.3

ug/l

212.2

118.5

0.17

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.12

1.44

9.5

6.7

—

(3001729) Color of Synovial fluid

3.13

1.44

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.97

1.43

2.4

3.7

mg/l

9.2

7.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

748

0.74

1.41

1.9

1.7

mg/l

11.0

3.7

0.89

520

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.86

1.40

1.1

69.4

93.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.42

1.39

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.94

1.38

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

158

1.59

1.37

2.9

2.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.2

1.7

—

(3025315) Body weight

2.94

1.36

5.6

3.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.94

1.36

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

151

1.59

1.34

1.1

—

(3039000) Anion gap in Blood

505

1.31

1.34

14.5

7.7

mmol/l

10.6

11.2

0.93

449

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.04

1.32

3.3

2.3

mmol/l

7.9

7.8

—

(3018572) Chloride [Moles/volume] in Blood

506

1.31

1.32

14.5

7.7

mmol/l

105.4

105.3

0.04

450

(40768800) Prostate Pathology biopsy report

521

0.71

1.31

1.1

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.78

1.28

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

2.78

1.28

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

554

1.29

1.27

1.1

u/ml

1.0

5.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

615

6604

0.91

1.26

4.0

4.4

24.0

21.7

2.69

289

3286

(3047007) Chlamydophila sp Ab [Presence] in Serum

294

1.40

1.26

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2062

21049

0.91

1.26

5.0

4.9

mmol/l

2.5

2.7

13.16

1857

19285

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

107

1.69

1.25

3.4

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

320

1.38

1.25

5.6

5.1

umol/l

405.3

360.4

1.14

285

(3039443) Prostate specific Ag panel - Serum or Plasma

422

0.68

1.24

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.04

1.22

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.17

1.21

2.5

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.17

1.21

2.6

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.17

1.21

2.6

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

151

1286

1.18

1.21

1.3

1.2

iu/ml

138.1

145.2

0.08

470

(3036071) Salmonella sp Ab [Titer] in Serum

1.80

1.21

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

156

1.54

1.20

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.11

1.18

1.0

1.1

—

(4094501)

567

0.74

1.17

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

2.00

1.16

1.2

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

257

1.41

1.15

1.4

1.6

62.9

63.5

0.03

160

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

103

1.65

1.12

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.34

1.12

1.0

—

(3020650) Glucose [Presence] in Urine

1.90

1.12

1.3

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.96

1.11

1.9

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.26

1.10

1.0

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

140

1197

1.18

1.09

3.6

3.3

pmol/l

4.2

4.5

2.68

125

1047

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

738

1.23

1.09

1.6

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

1.09

7.9

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

1.09

7.9

2.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.12

1.05

1.1

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

199

2249

0.88

1.04

1.6

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

162

1.49

1.04

1.5

1.2

u/ml

0.4

0.8

0.42

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

240

2678

0.89

1.03

13.7

7.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

246

1.39

1.03

1.8

1.5

nmol/l

0.9

0.3

0.41

196

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

554

1.25

1.02

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

139

1.51

1.00

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.18

0.98

2.4

2.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

163

1856

0.87

0.97

1.8

2.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.15

0.91

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

159

1.45

0.91

1.5

1.4

u/ml

12.9

21.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.79

0.87

2.3

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

861

8233

1.07

0.86

4.6

5.1

ug/l

3.7

0.02

738

7346

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.85

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2014

20481

0.93

0.85

4.5

4.4

mmol/l

1.4

13.06

1812

18756

(3024263) Appearance of Synovial fluid

112

1.52

0.84

1.2

1.6

—

(3015183) Erythrocyte sedimentation rate

1.57

0.84

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

274

1.32

0.84

1.1

u/ml

10.0

2.6

0.41

106

(40757494) Bilirubin.total [Moles/volume] in Blood

121

1.49

0.82

2.6

2.7

umol/l

47.6

48.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

172

1.40

0.81

1.3

1.4

mmol/l

12.9

12.8

0.02

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.70

0.80

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.56

0.78

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1109

0.86

0.74

2.0

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

243

2650

0.91

0.74

4.1

4.5

31.6

32.4

0.53

176

1775

(3041806) Other cells [#/volume] in Blood by Manual count

1.64

0.73

1.2

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.72

3.0

2.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

125

1.44

0.72

1.1

u/l

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

416

1.23

0.72

1.7

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

229

1.31

0.71

1.2

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.92

0.70

2.2

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.71

0.70

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

887

0.85

0.68

1.9

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

302

1.26

0.68

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

312

1.25

0.66

1.8

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

103

1.46

0.65

10.1

14.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.73

0.64

1.2

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.73

0.64

2.4

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

323

1.24

0.63

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

1.43

0.63

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.52

0.62

1.5

2.8

ug/l

1.0

1.7

1.15

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

138

1.38

0.62

1.0

1.1

iu/ml

10.3

10.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

343

0.78

0.58

1.1

u/ml

0.4

1.7

—

170

(3008898) HLA-B27 [Presence]

667

0.85

0.56

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.62

0.55

2.0

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

177

1.30

0.54

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

140

1273

1.11

0.53

1.4

1.3

au/ml

16.9

56.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.43

0.53

1.1

3.5

umol/l

56.0

125.3

—

(3005033) Fetal Nuchal fold Thickness US

314

1.21

0.52

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.41

0.51

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

425

1.18

0.51

1.3

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

499

0.84

0.50

2.1

1.9

iu/l

3.4

4.7

0.91

179

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.39

0.50

2.6

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

454

1.17

0.50

1.4

1.9

nmol/l

0.9

0.8

0.40

375

(3021387) Prolactin [Units/volume] in Serum or Plasma

660

1.14

0.50

1.8

1.6

mu/l

331.9

301.3

0.37

604

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2041

20640

0.95

0.49

4.6

4.4

mmol/l

4.3

4.6

17.72

1850

19037

(3047352) Trisomy 18 risk [Likelihood] in Fetus

316

1.21

0.49

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

643

1.14

0.48

5.6

1.9

—

(44813793)

137

1.32

0.47

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.46

0.46

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

351

0.82

0.44

1.1

u/ml

1.7

5.2

2.71

199

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.61

0.43

2.6

1.4

ng/l

120.2

123.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

192

2053

0.93

0.42

1.9

2.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

531

5501

0.96

0.40

1.9

1.6

mmol/l

1.4

0.24

435

4603

(4034850)

698

0.89

0.40

23.4

9.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

541

1.13

0.39

6.4

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

183

1717

1.07

0.38

2.3

2.2

nmol/l

12.7

12.6

0.09

157

1508

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.34

0.38

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.37

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.35

0.37

9.0

7.9

—

(3000764) Benzodiazepines [Presence] in Urine

687

1.11

0.36

5.4

1.9

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

282

1.17

0.35

1.7

1.3

nmol/l

0.7

0.6

0.13

267

(3027008) Opiates [Presence] in Urine

692

1.10

0.33

5.4

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

239

1.17

0.31

1.4

pmol/l

280.6

282.3

0.01

182

(3028300) Cannabinoids [Presence] in Urine

695

1.10

0.31

5.5

1.9

—

(37021550) Renin [Units/volume] in Plasma --upright

1.32

0.30

1.4

mu/l

103.6

57.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.30

0.30

1.0

3.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

334

1.14

0.30

1.4

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.31

0.30

5.0

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

260

1.16

0.28

1.7

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

262

2731

0.95

0.28

1.6

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

545

1.10

0.28

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

130

1.23

0.28

1.2

—

(3005570) Glucose [Moles/volume] in Urine

232

1.17

0.28

2.7

2.1

—

(3027944) Amphetamines [Presence] in Urine

680

1.09

0.28

5.5

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

1.26

0.28

1.4

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

395

0.88

0.26

1.2

1.1

u/ml

0.5

2.4

2.40

184

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

179

1.17

0.25

4.0

4.9

u/ml

45.2

42.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

266

0.86

0.25

1.0

u/ml

0.9

3.3

—

118

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

463

4752

0.97

0.24

2.9

3.1

ug/l

0.8

0.42

320

3224

(3037556) Urate [Mass/volume] in Serum or Plasma

0.72

0.24

1.5

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.32

0.23

5.2

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.32

0.23

2.6

2.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

243

0.86

0.23

1.6

1.3

mmol/l

7.9

7.4

0.23

173

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1926

19395

0.97

0.23

6.5

5.9

mmol/mol

39.6

40.1

1.42

1753

17871

(3003740) Influenza virus B Ag [Presence] in Specimen

333

1.11

0.22

1.4

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.22

0.22

1.6

2.3

umol/l

10.0

17.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

336

0.89

0.21

1.1

u/ml

0.8

2.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

107

1.22

0.21

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

11.9

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.21

0.0

1.0

—

165.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

11.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.1

—

(4133840)

1.22

0.20

1.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

203

1.13

0.19

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

697

1.06

0.18

1.9

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

173

1792

0.96

0.17

1.5

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.17

1.0

1.1

—

(4146454)

246

0.89

0.16

3.0

2.6

—

(3000492) Spirometry study

202

1960

1.03

0.15

1.5

—

(3011288) Drugs identified in Urine by Screen method

469

1.07

0.14

16.2

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

357

0.92

0.14

1.4

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

249

1.09

0.12

1.7

1.3

nmol/l

—

(3003338) MCHC [Mass/volume]

1781

17889

0.99

0.11

45.7

18.9

g/l

331.6

332.5

3.24

1764

17734

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

107

1037

1.03

0.10

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

249

0.92

0.10

1.0

1.1

u/ml

3.9

5.0

—

115

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2045

20387

1.01

0.10

5.1

4.6

mmol/l

6.1

6.0

1.84

1860

18425

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

389

1.05

0.09

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1973

19790

0.99

0.09

4.3

4.0

mmol/l

1.3

1.53

1787

17992

(40768793) Breast Pathology biopsy report

419

1.05

0.09

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.11

0.09

1.2

1.0

—

4.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

390

1.05

0.08

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

390

1.05

0.08

1.3

1.4

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.77

0.08

1.0

mu/l

9.1

9.2

—

(4015189)

1.09

0.08

3.0

2.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

391

1.05

0.08

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

698

7034

0.99

0.08

3.2

2.9

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

108

1.11

0.07

5.6

11.9

mmol/l

0.5

0.6

0.47

100

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.84

0.07

1.1

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.82

0.07

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

178

1.07

0.05

3.2

3.1

mg/l

13.4

32.8

1.12

136

(3006653) Thiamine [Moles/volume] in Blood

110

1.09

0.05

1.0

1.3

nmol/l

141.2

141.6

0.01

110

(1002224) Polysomnography panel

770

1.01

0.02

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

107

0.93

0.02

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

352

1.02

0.01

2.2

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

121

0.99

0.00

1.0

1.2

u/ml

3.4

2.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

225

0.98

0.00

1.2

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

146

1.03

0.00

1.0

—

(4024509)

196

1.02

0.00

2.0

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

208

1.01

0.00

2.3

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

272

0.99

0.00

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

483

0.99

0.00

1.2

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

117

1.03

0.00

6.7

6.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.97

0.00

1.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

51.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.93

0.00

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

2.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.98

0.00

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

0.98

0.00

2.4

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.7

—

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_THROMBOCYTOPENIANAS and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_THROMBOCYTOPENIANAS	2.959 [2.61, 3.36]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.239

During the follow-up period (1.1.1998 — 31.12.2019), 2428 out of 7148 females with D3_THROMBOCYTOPENIANAS died.

Males

Parameter	HR [95% CI]	p-value
D3_THROMBOCYTOPENIANAS	3.095 [2.72, 3.52]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.474

During the follow-up period (1.1.1998 — 31.12.2019), 3444 out of 8372 males with D3_THROMBOCYTOPENIANAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_THROMBOCYTOPENIANAS.

N-year risk	Females	Males
1	0.242%	0.6%
5	1.655%	4.353%
10	4.4%	10.977%
15	8.294%	19.863%
20	14.628%	32.578%

Relationships between endpoints

↥

Index endpoint: D3_THROMBOCYTOPENIANAS – Thrombocytopenia, unspecified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Thrombocytopenia, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints